ViennaLab

ViennaLab

ViennaLab is proud of its engagement in product development, promoting original IVD StripAssay® and RealFastTM kits worldwide with its existing network of distribution partners, guaranteeing international presence.

ViennaLab Diagnostics offers a variety of easy-to-use in vitro diagnostic kits for the detection of genetic mutations, as well as genetic predispositions, pharmacogenetics and oncology.

ViennaLab StripAssays® and RealFast™ Assays are easy, reliable and affordable – better than any other assay currently on the market.

StripAssays®

Human diagnostic assays for genotyping mutations and polymorphisms (SNPs, deletions, insertions) based on polymerase chain reaction (PCR) and reverse-hybridzation to allele-specific oligonucleotide probes immobilized on teststrips

  • Simple and straightforward protocols
  • Manual or automated
  • Less than 6 hours from DNA to result
  • Easy and clear interpretation of results
  • Additional mutations readily integrated
  • Ready-to-use reagents; inexpensive equipment; CE/IVD labeled kits; sensitive and affordable
01

FMF StripAssay®

Testing for Familial Mediterranean Fever and Risk Factors for Amyloidosis
02

CAH StripAssay®

Congenital adrenal hyperplasia (CAH) is an inherited disorder of steroid hormone synthesis.
03

CF StripAssay®

Identify the most relevant CFTR mutations and variants for newborn screening and confirmatory genotyping
04

Lactose Intolerance StripAssay®

Many people do not have the necessary enzymes in sufficient quantities to digest lactose and fructose.
05

Sugar Intolerance StripAssay®

ViennaLab assays identify the most frequent genetic variations responsible for sugar intolerance.
06

PGX-Thrombo StripAssay®

ViennaLab assays identify the most relevant genetic variations influencing coumarin anticoagulation therapy.
07

PGX-TPMT StripAssay®

The PGX-TPMT StripAssay® identifies the most frequent polymorphisms in the TPMT gene with therapeutic relevance.
08

PGX-CYP2C19 StripAssay®

The PGX-CYP2C19 StripAssay® detects genetic variants resulting in reduced or increased activity of the cytochrome P450 isoenzyme CYP2C19.
09

PGX-CYP2D6 StripAssay®

The PGX-CYP2D6 StripAssay® detects the most common variants with impaired enzyme activity.
10

BRAF 600/601 StripAssay®

The BRAF StripAssays® rapidly identify the most relevant mutations in the BRAF gene.
11

NRAS XL StripAssay®

The KRAS and NRAS StripAssays® rapidly identify the most relevant mutations in the KRAS and NRAS genes.
12

KRAS XL StripAssay®

The KRAS and NRAS StripAssays® rapidly identify the most relevant mutations in the KRAS and NRAS genes.
13

EGFR XL StripAssay®

The EGFR StripAssay® identifies the most important mutations relevant for anti EGFR-TK therapy
14

HLA-B27 StripAssay®

ViennaLab HLA-B27 assays detect all disease-relevant HLA-B27 subtypes.
15

CVD StripAssay® T

CVD StripAssays® and RealFast™ Assays identify various combinations of genetic CVD risk factors.
16

CVD StripAssay® A

Identify the most relevant genetic variations to estimate the risk for Cardiovascular Diseases

17

Haemochromatosis StripAssay® B

ViennaLab assays identify the most common mutations causing iron overload.

RealFast™ Assays

RealFastTM Assays based on real-time PCR detect single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) fast and simply.

  • Fast and easy handling
  • Same protocol for all genotyping assays
  • Less than 90 min from DNA to result
  • Controls for wild type and mutant genotypes included
  • Compatible with many real-time PCR instruments
  • Ready-to-use reagents; inexpensive equipment; CE/IVD labeled kits; sensitive and affordable
01

FV Leiden RealFast™ Assay

Detects the most common genetic risk factor associated with venous thromboembolism, the 1691G>A mutation in the Factor V (FV) gene

02

FV-PTH mpx RealFast™ Assay

Simultaneous detection of the most important thrombophilic mutations 1691G>A in the Factor V gene and 20210G>A in the prothrombin gene

03

PTH 20210G>A RealFast™ Assay

Detects the second most important genetic risk factor for venous thromboembolism in the prothrombin (PTH) gene

04

HFE C282Y RealFast™ Assay

Detect common mutations in the HFE gene causing hereditary haemochromatosis (HH) type 1

05

HFE mpx RealFast™ Assay

Simultaneous detection of the two most common mutations in the HFE gene: H63D and C282Y

06

LCT -13910C>T RealFast™ Assay

Detects the most common polymorphism in the lactase (LCT) gene causing lactase non-persistence
07

MTHFR 677C>T RealFast™ Assay

Detect common mutations in the methylenetetrahydrofolate reductase (MTHFR) gene causing hyperhomocysteinemia, which is a risk factor for cardiovascular disease
08

MTHFR mpx RealFast™ Assay

Simultaneous detection of the most common two mutations in the MTHFR gene: 677C>T and 1298A>C
09

MTHFR 1298A>C RealFast™ Assay

Detect common mutations in the methylenetetrahydrofolate reductase (MTHFR) gene causing hyperhomocysteinemia, which is a risk factor for cardiovascular disease
10

PAI-1 4G/5G RealFast™ Assay

Detects the 4G risk allele in the plasminogen activator inhibitor-1 (PAI-1) gene, associated with cardiovascular disease and pregnancy complications
11

SLCO1B1c.521T>C RealFast™ Assay

Detects a variant in human solute carrier organic anion transporter family member 1B1 (SLCO1B1) gene in patients who are at higher risk for developing statin-induced myopathy

12

HLA-B5701 RealFast™ Assay

Detects human leukocyte antigen-B (HLA-B) 5701 allele, which is associated with hypersensitivity to the anti-HIV drug abacavir

13

HLA-B27 RealFast™ Assay

Detects the human leukocyte antigen-B (HLA-B) 27 allele, which is associated with ankylosing spondylitis

14

EGFR T790M RealFast™ Assay

Detects the T790M mutation in the EGFR gene from cell-free DNA. For monitoring of lung cancer patients who undergo treatment with EGFR tyrosine kinase inhibitors.